透皮给药系统市场预计将从 2022 年的 372.3028 亿美元增长到 2030 年的 519.4974 亿美元;预计 2022 年至 2030 年的复合年增长率为 4.3%。制造商的战略举措可能仍将是市场的一个主要趋势。
透皮给药系统市场分析
慢性病发病率不断上升、对非侵入性药物输送设备的需求不断增长以及对自我用药的高需求是市场增长的主要驱动因素。此外,采用 3D 打印技术和智能贴片可能会在未来几年为透皮药物输送系统市场带来机遇。
透皮给药系统市场概览
心血管疾病 (CVD),如心绞痛、动脉粥样硬化、心力衰竭和急性心肌梗塞,是全球常见的死亡原因之一。根据世界卫生组织的数据,心血管疾病是全球每年约 1790 万人死亡的主要原因。市面上有许多用于治疗心血管疾病的药物,但传统的胶囊和药片无法有效控制疾病。这强调了对新型药物输送系统的需求,该系统可以提供更长的药物生物利用度,并将药物靶向输送到心血管系统的受影响区域。透皮药物输送系统在治疗心血管疾病方面比常规口服药物具有许多优势。透皮贴剂包含药物颗粒,可应用于皮肤表面。心脏贴剂为细胞植入改进提供了极好的平台。例如,最近开发的血管化心脏贴剂显示出治疗缺血性心脏损伤的良好潜力。硝酸甘油透皮贴剂用于预防冠状动脉疾病患者的心绞痛(胸痛)发作。它们的作用是放松血管,减少心脏压力,降低对氧气的需求。但是,这些贴片不能用于治疗已经开始的心绞痛。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
透皮给药系统市场驱动因素和机遇
持续的技术进步
传统的药物输送技术,如肌肉注射、静脉注射和直肠给药,并不受特定患者群体的青睐,主要是因为这些技术会带来疼痛和复杂性。随着医学科学的进步和明确的药物输送技术,非侵入性药物输送系统现已准备好与传统的注射给药方法竞争。非侵入性药物输送系统包括口服、外用、透皮主动(设备辅助增强渗透)和透皮被动给药;吸入药物的透眼膜、透粘膜和肺泡膜。透皮给药在许多方面都优于口服给药途径。特别是,它避开了肝脏的首过机制,否则肝脏会冲动地代谢药物。
智能贴片和 3D 打印贴片的进步
透皮给药途径是一种新颖且可靠的持续给药方式之一。随着该领域的大量研究以及研究人员对这种给药方式的兴趣日益浓厚,许多透皮贴剂很可能在未来进入市场。透皮贴剂用于输送尼古丁、芬太尼、硝酸甘油和可乐定等药物,以治疗各种疾病。最近,这些贴剂已被探索用于在各种应用中输送生物制剂。智能贴片配备了传感器和其他技术,可监测患者状况并相应地调整药物输送。2023 年 1 月,斯旺西大学的一位首席科学家开发了一种新的智能贴片,使用微针技术检测帕金森病和阿尔茨海默病等神经退行性疾病的促炎生物标志物。这些智能贴片由许多微针组成,旨在以微创方式穿透皮肤屏障,然后监测具有临床意义的生物标志物。它们可以在全科医生或家中自行给药以进行即时诊断。这项创新研究可能会改变早期神经退行性疾病检测的格局。
透皮给药系统市场报告细分分析
有助于得出透皮给药系统市场分析的关键部分是产品和最终用户。
- 根据类型,透皮给药系统市场细分为透皮贴剂、透皮凝胶、透皮喷雾剂等。透皮贴剂部分在 2022 年占据了最大的市场份额。
- 根据应用,透皮给药系统市场分为心血管疾病、中枢神经系统疾病、疼痛管理、激素应用、其他应用。疼痛管理领域在 2022 年占据了最大的市场份额。
- 根据分销渠道,透皮给药系统市场分为医院药房、零售药房、网上药房等。医院药房部分在 2022 年占据了最大的市场份额。
透皮给药系统市场份额按地区分析
透皮给药系统市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。
美国是北美最大的透皮给药系统市场。根据美国心脏协会 (AHA) 的数据,心血管疾病 (CVD) 仍然是美国的主要死亡原因。根据 CDC 的数据,2021 年,CVD 导致约 695,000 人死亡,约占美国死亡人数的五分之一。心血管疾病、糖尿病、慢性疼痛和其他慢性疾病的患病率不断上升,推动了对有效和便捷治疗方案的需求。医疗贴片提供了一种非侵入性且对患者友好的方法来输送药物并控制与这些慢性病相关的症状。TDDS 的持续进步,例如可穿戴传感器和柔性电子产品,促进了透皮给药系统市场的增长。这些进步可以实现更准确的剂量、患者监测和依从性。根据《生物材料研究》2021年发表的一篇题为《透皮给药系统的最新进展》的报告,在透皮给药系统模式中,微针引起了极大的关注,它通过结合微针的优点来克服现有简单应用型和贴片型针的局限性,从而获得更高的治疗效率和效果。这些透皮给药系统的进展可以为控制心血管和中枢神经系统疾病、糖尿病、神经肌肉疾病以及传染性和局部性传染病的流行提供驱动力。
透皮给药系统市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响透皮给药系统市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的透皮给药系统市场细分和地理位置。
- 获取透皮给药系统市场的区域特定数据
透皮给药系统市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 372.3028亿美元 |
2030 年的市场规模 | 519.4974亿美元 |
全球复合年增长率(2022 - 2030 年) | 4.3% |
史料 | 2020-2021 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
透皮给药系统市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在透皮给药系统市场运营的主要公司有:
- 诺华公司
- 葛兰素史克公司
- 维他命公司
- 勃林格殷格翰国际有限公司
- 拉维制药公司
- 久光制药株式会社
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解透皮给药系统市场主要参与者的概况
透皮给药系统市场新闻和最新发展
通过收集主要和次要研究后的定性和定量数据来评估透皮给药系统市场,其中包括重要的公司出版物、协会数据和数据库。透皮给药系统市场的一些发展如下所列:
- Starton Therapeutics Inc. 已向美国专利商标局 (USPTO) 提交了临时专利申请,要求采用独特和新颖的方法将各种活性药物成分 (API) 整合到透皮给药系统中,而此类 API 通常很难整合到透皮给药系统平台中。(来源:Starton Therapeutics,公司网站,2024 年 1 月)
- Satio 已从美国卫生高级研究计划署 (ARPA-H)、美国国立卫生研究院、美国卫生与公众服务部获得一份价值 350 万美元的小型企业创新研究 (SBIR) 合同。这款 SatioRx 设备设计紧凑且价格低廉,配有一次性微针组件,可让医疗保健提供者远程输送经 FDA 批准用于透皮给药的任何液体药物的精确计量剂量。根据这份合同,Satio 将利用其其他贴片设备的设计特点和其手动操作透皮给药设备的可行性数据来开发下一代可远程控制的设备。(来源:Satio,公司网站,2023 年 9 月)
透皮给药系统市场报告覆盖范围和交付成果
“透皮给药系统市场规模和预测(2020-2030 年)”报告对以下领域进行了详细的市场分析:
- 透皮给药系统市场规模及全球、区域和国家层面所有主要细分市场的预测
- 透皮给药系统市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 透皮药物输送系统市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及透皮给药系统市场的最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Adaptive Traffic Control System Market
- Customer Care BPO Market
- Cosmetic Bioactive Ingredients Market
- Virtual Pipeline Systems Market
- Microplate Reader Market
- Hand Sanitizer Market
- Pharmacovigilance and Drug Safety Software Market
- Europe Industrial Chillers Market
- Digital Pathology Market
- Nitrogenous Fertilizer Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.3% during 2023–2031.
Novartis AG, GSK Plc, Viatris Inc, Boehringer Ingelheim International GmbH, Lavipharm SA, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Purdue Pharma LP.
Strategic initiatives by manufacturers will likely remain a key trend in the market.
The increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery devices, and high demand for self-administration of drugs are the key driving factors behind the market growth.
North America dominated the transdermal drug delivery system market in 2023
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.